These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8874437)

  • 41. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
    Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relative importance of quantifying area and vascular patterns in uveal melanomas.
    Mehaffey MG; Folberg R; Meyer M; Bentler SE; Hwang T; Woolson R; Moore KC
    Am J Ophthalmol; 1997 Jun; 123(6):798-809. PubMed ID: 9535624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumour thickness, diameter, area or volume? The prognostic significance of conventional versus digital image analysis-based size estimation methods in uveal melanoma.
    Arnljots TS; Al-Sharbaty Z; Lardner E; All-Eriksson C; Seregard S; Stålhammar G
    Acta Ophthalmol; 2018 Aug; 96(5):510-518. PubMed ID: 29338132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prognostic value of tumor blood vessel morphology in primary uveal melanoma.
    Folberg R; Rummelt V; Parys-Van Ginderdeuren R; Hwang T; Woolson RF; Pe'er J; Gruman LM
    Ophthalmology; 1993 Sep; 100(9):1389-98. PubMed ID: 8371929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. JARID1B protein expression and prognostic implications in uveal melanoma.
    Radberger P; Radberger A; Bykov VJ; Seregard S; Economou MA
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4442-9. PubMed ID: 22669717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
    Coupland SE; Campbell I; Damato B
    Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereologic estimation of nucleolar volume in ocular melanoma: a comparative study of size estimators with prognostic impact.
    Sørensen FB; Gamel JW; McCurdy J
    Hum Pathol; 1993 May; 24(5):513-8. PubMed ID: 8491491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diffuse malignant melanoma of the uvea. A clinico-histopathologic study of 39 patients].
    Braun UC; Rummelt VC; Naumann GO
    Klin Monbl Augenheilkd; 1998 Dec; 213(6):331-40. PubMed ID: 10048010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathological and prognostic features of uveal melanomas.
    McLean IW; Saraiva VS; Burnier MN
    Can J Ophthalmol; 2004 Jun; 39(4):343-50. PubMed ID: 15327098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival from uveal melanoma in Western Australia 1981-2005.
    Chew AL; Spilsbury K; Isaacs TW
    Clin Exp Ophthalmol; 2015 Jul; 43(5):422-8. PubMed ID: 25556534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival after primary enucleation of largest uveal melanomas.
    Gambrelle J; Kodjikian L; Grange JD
    Acta Ophthalmol Scand; 2005 Jun; 83(3):398; 398-9. PubMed ID: 15948802
    [No Abstract]   [Full Text] [Related]  

  • 52. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The follow up of prognostic important factors and analysis of five years survival rate in patients with uveal melanoma at the Department of Ophthalmology, 3rd Medical Faculty Charles University in Prague and the Faculty Hospital Královské Vinohrady in Prague].
    Redinová MV; Sach J; Baráková D; Kuchynka P; Vránová J
    Cesk Slov Oftalmol; 2009 Jan; 65(1):29-35. PubMed ID: 19366035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic associations of insulin-like growth factor-1 receptor in primary uveal melanoma.
    Al-Jamal RT; Kivelä T
    Can J Ophthalmol; 2011 Dec; 46(6):471-6. PubMed ID: 22153631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and cytogenetic analyses in uveal melanoma.
    Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A reappraisal of the significance of largest basal diameter of posterior uveal melanoma.
    Damato B; Coupland SE
    Eye (Lond); 2009 Dec; 23(12):2152-60; quiz 2161-2. PubMed ID: 19876071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparative study of morphometric measurements of nucleoli in uveal melanomas from electron micrographs and plastic-embedded and paraffin-embedded sections.
    Mikel UV; Engler WF; Perez-Rosario E; Becker RL; McLean IW
    Anal Quant Cytol Histol; 1989 Apr; 11(2):111-4. PubMed ID: 2719797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
    Shah AA; Bourne TD; Murali R
    Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
    Ghazvini S; Kroll S; Char DH; Frigillana H
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.